Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanotechnology-Based Medical Anti-Friction Coating

ApNano Materials Announces Nanotechnology-Based Medical Anti-Friction Coating

New York, NY | Posted on September 12, 2006

ApNano Materials, Inc. (www.apnano.com), a provider of nanotechnology-based products, today announced an anti-friction medical coatings line, based on NanoLub – ApNano Material's nanotechnology-based solid lubricant. The medical friction-reduction coatings are intended to be used in a variety of medical applications such as guide-wires in catheters, which are used in invasive treatments such as cardiac catheterization, orthodontic wires and braces for teeth straightening, and coatings for artificial joints and hips.

"Frictionless inserts, such as guide-wires in catheters, can reduce pain, limit tissue damage and improve the accurateness and the success of medical procedures," said Dr. Menachem Genut, President and CEO of ApNano Materials. "In addition, the new medical coatings have the potential to significantly reduce friction in implants, such as artificial joints, extensively prolonging implant's life and preventing frequent repetitive operations."

"NanoLub was found to be non-toxic in a variety of tests performed by accredited independent testing laboratories, certified to be in complete compliance with international standards of the OECD (Organization for Economic Co-Operation and Development)," said. Dr. Niles Fleischer, VP Business and Product Development, ApNano Materials. "The acute toxicity testing was done in full accordance with European Commission directives for Good Laboratory Practice (GLP)."

NanoLub is based on revolutionary nanoparticles of tungsten disulfide, (WS2), termed inorganic fullerene-like nanostructures, or IF for short. Fullerenes are soccer ball-like clusters of atoms, named after R. Buckminster Fuller, architect of the geodesic dome that he designed for the 1967 Montreal World Exhibition. The inorganic fullerenes were first discovered in breakthrough work in nanotechnology performed at the Weizmann Institute of Science, Israel, by a group headed by Professor Reshef Tenne, currently the Head of the Institute's Department of Materials and Interfaces. Dr. Menachem Genut, ApNano Materials' President and CEO was a research fellow in the original research team which discovered the IF nanoparticles at the Weizmann Institute and first to synthesize the new material.

In research work conducted in the laboratory of Prof. Tenne and funded by ApNano Materials, composite coatings containing IF were developed. Tribological tests performed by Prof. Lev Rapoport of the Holon Institute of Technology (HIT) demonstrated significantly reduced friction and wear of these self-lubricating coatings. In a work done in collaboration with Prof. Tenne by Drs. Meir Redlich and Alon Katz (both from the Faculty of Dental Medicine, Hebrew University, Hadassah Medical Organization, Israel), the friction force of orthodontic wires coated with IF-WS2 nanoparticles embedded in metallic coatings showed more than 50% reduction in friction compared to non-coated wires.

According to Mr. Aharon Feuerstein, Chairman and CFO of ApNano Materials "ApNano Materials, after having initial very encouraging test results, is in advanced negotiations with leading medical device manufacturers worldwide, to integrate NanoLub in existing and future medical product lines."

####

About ApNano Materials:
ApNano Materials (www.apnano.com) is a private nanotechnology company founded in 2002 by Dr. Menachem Genut, President and CEO and Mr. Aharon Feuerstein, Chairman and CFO. ApNano Materials was incorporated in the US and is headquartered in New York, USA. Its fully-owned Israeli subsidiary - NanoMaterials, Ltd., is located in the high tech science park adjacent to the Weizmann Institute campus in Ness Ziona, Israel. The company was granted an exclusive license by Yeda Research and Development Co. Ltd, the commercial arm of the Weizmann Institute of Science, Israel, to manufacture, commercialize and sell a new class of nanomaterials based on inorganic compounds that were discovered at the Institute. The shareholders of ApNano Materials, besides the founders, are Newton Technology VC Fund, Yeda Research and Development Co. LTD. (the commercial arm of the Weizmann Institute of Science), AYYT Technological Applications and Date Update LTD. (the commercial arm of Holon Institute of Technology (HIT), Israel), and private European investors.

NanoLub, a green, environmentally friendly material, is a trademark of ApNano Materials, Inc.

For more information, please click here.

Contact:
David Kanaan
Kanaan Public Relations
Tel.: +972-3-5408188
david@kanaan.co.il

Copyright © ApNano Materials

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Products

Spectradyne Partners with Particle Technology Labs for Measurement Services December 6th, 2018

Mode-Changing MEMS Accelerometer from STMicroelectronics Combines High Measurement Resolution and Ultra-Low Power for Industrial Applications November 7th, 2018

Fat-Repellent Nanolayers Can Make Oven Cleaning Easier October 17th, 2018

Aculon, Inc. Enters into Strategic Partnership Agreement with Henkel Corporation to Supply Key Mobile Device Manufacturers with NanoProof® PCB Waterproof Technology October 17th, 2018

Nanomedicine

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery: NYU Abu Dhabi researchers develop novel covalent organic frameworks for precise cancer treatment delivery September 13th, 2024

Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024

Nanobody inhibits metastasis of breast tumor cells to lung in mice: “In the present study we describe the development of an inhibitory nanobody directed against an extracellular epitope present in the native V-ATPase c subunit.” August 16th, 2024

Announcements

Nanotechnology: Flexible biosensors with modular design November 8th, 2024

Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024

Turning up the signal November 8th, 2024

Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project